D. Eshima

发表

Evaluation of technetium-99m-triamide-mercaptide complexes designed to identify properties favoring renal tubular transport.

L. Hansen, L. Marzilli, D. Eshima, 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Technetium-99m (99mTc) mercaptoacetyltriglycine: update on the new 99mTc renal tubular function agent.

D. Eshima, A. Taylor, Andrew M. Taylor, 1992, Seminars in nuclear medicine.

Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers.

P. Christian, D. Eshima, A. Taylor, 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Comparison of Tc-99m MAG3 and Tc-99m DTPA in Renal Transplant Patients with Impaired Renal Function

J. Ziffer, D. Eshima, A. Taylor, 1990, Clinical nuclear medicine.

Comparison of technetium-99m-ll-EC isomers in rats and humans.

L. Hansen, L. Marzilli, D. Eshima, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

99mTc renal tubular function agents: current status.

D. Eshima, A. Taylor, A. Fritzberg, 1990, Seminars in nuclear medicine.

Biomodulation: An integrated approach to access and manipulate biological information

R. Griffey, D. Eshima, N. Matwiyoff, 1991 .

Tissue distribution properties of technetium-99m-diamide-dimercaptide complexes and potential use as renal radiopharmaceuticals.

D. Eshima, D. Johnson, A. Fritzberg, 1986, Journal of medicinal chemistry.

Biological distribution of 99mTc-labeled YIGSR and IKVAV laminin peptides in rodents: 99mTc-IKVAV peptide localizes to the lung.

D. Eshima, B. Rhodes, P. Zamora, 1993, Biochimica et biophysica acta.

Effect on advanced age on p-aminohippurate-induced inhibition of renal tubular secretion in male fischer 344 rats

L. Hansen, D. Eshima, R. Galinsky, 1990, Mechanisms of Ageing and Development.

Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers.

D. Eshima, A. Taylor, J. Vansant, 1997, Seminars in nuclear medicine.

Technetium-99m-sulfur colloid for lymphoscintigraphy: effects of preparation parameters.

D. Eshima, A. Taylor, J. Vansant, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Effect of protein binding on renal extraction of 131I-OIH and 99mTc-labeled tubular agents.

L. Hansen, L. Marzilli, D. Eshima, 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Evaluation of Tc-99m mercaptoacetyltriglycine in patients with impaired renal function.

P. Christian, D. Eshima, A. Taylor, 1987, Radiology.

Enhanced tumor imaging with pokeweed mitogen.

D. Eshima, N. Matwiyoff, D. Bitner, 1993, Nuclear medicine and biology.

Renal artery stenosis and ischemia. Effect on renal blood flow and extraction fraction.

D. Eshima, A. Taylor, 1994, Hypertension.

Radiation dosimetry for technetium-99m-MAG3, technetium-99m-DTPA, and iodine-131-OIH based on human biodistribution studies.

D. Eshima, A. Taylor, M. Stabin, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Early stage melanoma: lymphoscintigraphy, reproducibility of sentinel node detection, and effectiveness of the intraoperative gamma probe.

D. Eshima, A. Taylor, J. Vansant, 1996, Radiology.

Lymphoscintigraphic identification of sentinel lymph nodes: clinical evaluation of 0.22-micron filtration of Tc-99m sulfur colloid.

D. Eshima, N. Alazraki, L. Eshima, 1998, Radiology.

Radiopharmaceuticals for lymphoscintigraphy: including dosimetry and radiation considerations.

D. Eshima, D Eshima, T Fauconnier, 2000, Seminars in nuclear medicine.

Estimation of technetium-99m-MAG3 plasma clearance in adults from one or two blood samples.

D. Eshima, A. Taylor, C. Russell, 1989, Journal of Nuclear Medicine.

Animal evaluation of technetium-99m triamide mercaptide complexes as potential renal imaging agents.

L. Hansen, D. Eshima, A. Taylor, 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement.

D. Eshima, D. Johnson, D L Johnson, 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Comparison of 99mTc-N-pyridoxyl-5-methyltryptophan and 99mTc-N-(3-bromo-2,4,6-trimethylacetanilide)-iminodiace tate as hepatobiliary radiopharmaceuticals in rats.

D. Eshima, D. Johnson, D. Bloedow, 1984, Journal of pharmaceutical sciences.

Synthesis and evaluation of [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors.

J. Votaw, J. Hoffman, D. Eshima, 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Measuring technetium-99m-MAG3 clearance with an improved camera-based method.

D. Eshima, R. Folks, A. Taylor, 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Tuftsin receptor-binding peptide labeled with technetium: chemistry and preliminary in vitro receptor-binding study.

D. Eshima, E. Wong, R. Bell, 2001, Inorganic chemistry.

99mTc-MAG3, a new renal imaging agent: Preliminary results in patients

D. Eshima, N. Alazraki, A. Taylor, 2004, European Journal of Nuclear Medicine.

Fluorine-18-FPCT: a PET radiotracer for imaging dopamine transporters.

C. Kilts, J. Votaw, J. Hoffman, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Stereochemical studies in the development of technetium radiopharmaceuticals. 1. Fluxional racemization of technetium and rhenium penicillamine complexes

D. Eshima, D. Johnson, B. Hawkins, 1984 .

Effects of altered physiologic states on clearance and biodistribution of technetium-99m MAG3, iodine-131 OIH, and iodine-125 iothalamate.

D. Eshima, A. Taylor, 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Prospective validation of a single sample technique to determine technetium-99m-MAG3 clearance.

D. Eshima, R. Folks, A. Taylor, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A single-injection, two-sample method for measuring renal 99mTc-MAG3 clearance in both children and adults.

D. Eshima, A. Taylor, C. Russell, 1995, Nuclear medicine and biology.

Technetium-99m MAG3 kit formulation: preliminary results in normal volunteers and patients with renal failure.

P E Christian, P. Christian, D. Eshima, 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Iodophenylsulfonamide fatty acid analogs as potential myocardial imaging agents.

D. Eshima, A. Fritzberg, 1982, The International journal of applied radiation and isotopes.

Rhenium (Re) and technetium (Tc)‐99M oxocomplexes of neurotensin(8‐13)

D. Eshima, A. Bossuyt, D. Tourwé, 1999 .

Comparison of a new Tc-99m renal function agent, Tc-99m mercaptoacetyltriglycine, with I-131 OIH

D. Eshima, D. Johnson, A. Fritzberg, 1985 .